Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker

OBJECTIVE: To measure plasma levels of malondialdehyde (MDA), a marker of oxidative stress (OS), in patients with major depressive disorder (MDD) compared with healthy control (HC) subjects in order to determine if it is a possible biomarker of depression. METHODS: This prospective cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Mon, Miguel A, Ortega, Miguel A, García-Montero, Cielo, Fraile-Martinez, Oscar, Lahera, Guillermo, Monserrat, Jorge, Gomez-Lahoz, Ana M, Molero, Patricio, Gutierrez-Rojas, Luis, Rodriguez-Jimenez, Roberto, Quintero, Javier, Alvarez-Mon, Melchor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149615/
https://www.ncbi.nlm.nih.gov/pubmed/35615790
http://dx.doi.org/10.1177/03000605221094995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149615/
https://www.ncbi.nlm.nih.gov/pubmed/35615790
http://dx.doi.org/10.1177/03000605221094995

Ejemplares similares